MEDIFAST (MED)
(Delayed Data from NYSE)
$18.44 USD
+0.16 (0.88%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $18.46 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.44 USD
+0.16 (0.88%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $18.46 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Zacks.com featured highlights include: Delta Apparel, Medifast and Service Corp
by Zacks Equity Research
Zacks.com featured highlights include: Delta Apparel, Medifast and Service Corp
General Mills (GIS) Poised on Key Priorities, Costs Inflated
by Zacks Equity Research
General Mills' (GIS) core priorities, focus on the Accelerate strategy and saving initiatives have been aiding the company amid an inflated cost scenario.
Why Is Medifast (MED) Down 10.8% Since Last Earnings Report?
by Zacks Equity Research
Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 of the Best Efficient Stocks to Boost Your Portfolio
by Tirthankar Chakraborty
Delta Apparel (DLA), MEDIFAST (MED) & Service Corporation International (SCI) are at present the three top efficient stocks that need to be added to your portfolio.
Altria (MO) Benefits From Low-Risk Products, High Pricing
by Zacks Equity Research
Altria (MO) is gaining from rising popularity of IQOS and on!. Strong pricing for tobacco products is also driving revenue growth.
Medifast (MED) Looks Tempting: Rallies More Than 35% in a Year
by Zacks Equity Research
Medifast (MED) has been benefiting from the strength of its OPTAVIA lifestyle solution and coaching support system as well as strategic growth endeavors like technological advancements.
Brown-Forman (BF.B) Q1 Earnings Meet Estimates, Sales Increase
by Zacks Equity Research
Brown-Forman's (BF.B) Q1 results gain from growth across geographic regions, product categories and the Travel Retail channel.
Philip Morris (PM) Gains on IQOS, Beyond Nicotine Expansion
by Zacks Equity Research
Philip Morris (PM) is gaining from rising popularity of IQOS devices. The company is also progressing with the expansion of Beyond Nicotine products that cater to medical wellness.
3 Reasons Why Growth Investors Shouldn't Overlook Medifast (MED)
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Altria (MO) Hikes Dividend, Boosts Shareholders' Wealth
by Zacks Equity Research
Altria (MO) raises quarterly dividend by 4.7% to 90 cents per share. The company's new annualized dividend rate is $3.60 per share.
Hain Celestial (HAIN) Q4 Earnings Miss Estimates, Sales Down
by Zacks Equity Research
Hain Celestial's (HAIN) fourth-quarter performance reflects impacts of overlapping pandemic-led volume surge witnessed in the prior-year quarter.
The J.M. Smucker (SJM) Q1 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
The J.M. Smucker's (SJM) first-quarter fiscal 2022 results reflect lower earnings and sales. Results were hurt by divestiture impacts and cost inflation, which is likely to prevail.
Church & Dwight (CHD) Gains on High Demand Amid Cost Concerns
by Zacks Equity Research
Church & Dwight (CHD) has been benefiting from elevated demand amid the pandemic, including online. That said, elevated input costs and supply-chain headwinds weighed on its 2021 view.
Zacks.com featured highlights include: Deckers Outdoor, Medifast, Textron, Terex Corp and Sonos
by Zacks Equity Research
Zacks.com featured highlights include: Deckers Outdoor, Medifast, Textron, Terex Corp and Sonos
5 Top-Ranked Liquid Stocks to Bet on for Higher Returns in 2021
by Vaishali Doshi
Here are five top-performing liquid stocks, Deckers (DECK), Medifast (MED), Textron (TXT), Terex (TEX) and Sonos (SONO), which investors can consider for healthy returns.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Mondelez (MDLZ) Teams Up With MissFresh, Fuels China Expansion
by Zacks Equity Research
Mondelez (MDLZ) teams up with MissFresh to offer Oreo Zero on the latter's popular online retail platform. This will give online customers of China access to OREO's new sugar-free sandwiches.
SpartanNash's (SPTN) Earnings Beat in Q2, Sales Decline Y/Y
by Zacks Equity Research
SpartanNash (SPTN) posts weak sales in the second quarter of 2021 due to favorable sales in the previous year on higher pandemic-led demand.
Buy 5 Top-Ranked Efficient Stocks for a Solid Portfolio
by Tirthankar Chakraborty
MEDIFAST (MED), Smith & Wesson Brands (SWBI), Encore Wire (WIRE), Cavco Industries (CVCO) & Apple (AAPL) at present flaunt solid efficiency levels and are thus believed to provide stellar returns in the near future.
Medifast (MED) Loses 13.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Medifast (MED) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Medifast (MED) Fuels Digital Growth With OPTAVIA App Launch
by Zacks Equity Research
Medifast (MED) launches the OPTAVIA app, which is likely to enhance Clients' experience with Lean & Green recipes, along with access to past order record and account information among other things.
Zacks.com featured highlights include: Piper Sandler, Mueller Industries, Global Ship Lease, Medifast and Bassett Furniture
by Zacks Equity Research
Zacks.com featured highlights include: Piper Sandler, Mueller Industries, Global Ship Lease, Medifast and Bassett Furniture
Philip Morris (PM) Boosts Beyond Nicotine Options With OtiTopic
by Zacks Equity Research
Philip Morris (PM) acquires OtiTopic to expand offerings in the inhaled therapeutics and respiratory drug delivery platform. The move is part of the company's Beyond Nicotine strategy.
Inter Parfums (IPAR) Q2 Earnings Top Estimates, Sales up Y/Y
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2021 results reflect solid top-and bottom-line performance on growth in U.S. and European operations.
Sysco (SYY) Q4 Earnings & Revenues Top Estimates, View Raised
by Zacks Equity Research
Sysco's (SYY) fourth-quarter fiscal 2021 results reflect increased top and bottom lines as certain markets are reopening. Management lifts EPS view for fiscal 2022.